FORGOTTEN HISTORY: Bristolmyers - Caught on Camera

The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today

Bristol-Myers stock extends gains on reports of a potential merger with AstraZeneca. But caution is warranted in chasing the momentum in BMY shares today.

Barchart · Aug 3

Is Bristol-Myers Stock Underperforming the S&P 500?

Bristol-Myers has lagged behind the broader S&P 500 Index, and Wall Street remains cautious about this stock.

Barchart · Nov 28, 2025

Weak Guidance from Bristol-Myers Could Be Creating an Opportunity

Bristol-Myers stock fell after earnings, but analysts remain bullish which suggests that any dip in the stock may create a buying opportunity

MarketBeat · Feb 7, 2025

2 High-Yield Value Stocks to Buy Now

Here's a look at two dividend value stocks with high yields that Wall Street recommends buying.

Barchart · Nov 8, 2023

3 Buy-Rated S&P 500 Stocks to Scoop Up Near 52-Week Lows

Beaten-down blue-chip stocks, such as United Parcel Services, look poised to deliver double-digit returns to shareholders in the next year.

Barchart · Oct 10, 2023